Ezra Launches AI-Fueled, Whole-Body MRI in Seattle in Partnership with Imaging Leader RAYUS Radiology
27 Junio 2024 - 12:55PM
Ezra, the healthcare AI startup transforming early cancer detection
through whole-body MRI screening, today announced its expansion to
two new locations in the Seattle metro area – Bellevue and Issaquah
– in partnership with RAYUS Radiology, using its technology to
improve access to the MRI process and help individuals proactively
address cancer and disease as early as possible.
Ezra’s end-to-end cancer screening platform monitors for cancer
and 500+ other conditions in up to 13 organs. Ezra has pioneered
the use of AI in cancer screening, enhancing the process to ensure
patients are equipped and empowered with the most intimate
knowledge of their health. Ezra is the only company in the industry
leveraging proprietary AI across all three key components of the
cancer screening process: imaging, analysis, and reporting. As a
result, the company has found early cancer for 6% of customers
to-date, empowering them with the knowledge and insights they need
to seek treatment and ultimately impacting their recovery.
In April 2024, Ezra announced a nationwide partnership with
RAYUS Radiology, one of the leading providers of imaging services,
enabling Ezra to expand nationally across the U.S. RAYUS’
board-certified radiologists and imaging technologists will
leverage Ezra’s technology at the Bellevue and Issaquah locations
to start, with more anticipated in the coming months – bringing
Ezra’s total geographic footprint to 30+ locations across 6 states.
Ahead of launch, over 300 people joined Ezra’s waitlist in Seattle,
showcasing the consumer demand for greater access to disease
monitoring like this.
“Expanding our partnership to Seattle allows us to continue our
commitment to technological advancements. We have had tremendous
demand from patients with the desire to obtain a whole-body MRI
scan at our facilities, and we are excited to offer this service at
additional locations to serve that demand,” said Kim Tzoumakas, CEO
of RAYUS Radiology.
“Seattle has long been one of our most in-demand markets, so
opening our doors in this vibrant community is an important moment
in our journey,” said Emi Gal, founder and CEO of Ezra. “In a world
full of opportunities to optimize, people are craving more clarity
on their health – and we’re committed to responsibly empowering
them with the insights and support they so clearly want.”
“I am so excited to see Ezra extend its unique approach to early
disease detection to Seattle to help improve health outcomes,” said
Amir Dan Rubin, CEO & Founding Managing Partner of Healthier
Capital and former CEO of One Medical. "Ezra continues to
demonstrate its significant impact potential and scalability as it
reaches more people in the Pacific Northwest.”
Patients can schedule Ezra full-body MRI scans at both Seattle
locations. To obtain more information, including prices, visit
www.ezra.com or call 888.402.3972.
About EzraFounded in 2018 by Emi Gal, Ezra is a
New York-based healthcare AI company pioneering the use of
full-body MRI to detect cancer and 500+ other conditions in up to
13 organs in the body. By advocating for early cancer detection as
part of annual health screenings, Ezra is on a mission to create a
new standard of preventative care, providing people with the
necessary knowledge to make better decisions about their
health.
About RAYUS RadiologyRAYUS Radiology is the
nation's leading subspecialty practice for advanced diagnostic and
interventional radiology, with a network of imaging centers,
hospital partnerships and short- and long-term hospital solutions.
The organization, with more than 3,000 team members nationwide, is
committed to delivering clinical excellence in communities across
the United States. Driven by its affiliated subspecialized
radiologist network, cutting-edge technology, industry-leading
protocols and elite technologists, RAYUS produces replicable,
reliable results trusted by patients and referring providers. For
more information, visit www.RAYUSradiology.com.